Drug Shortage Report for MYXREDLIN
| Report ID | 241104 |
| Drug Identification Number | 02529602 |
| Brand name | MYXREDLIN |
| Common or Proper name | MYXREDLIN Human Insulin 100 units / 100 mL in 0.9% Sodium Chloride |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN |
| Strength(s) | 1UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | CA2G3322 |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-10-28 |
| Actual start date | 2024-10-28 |
| Estimated end date | 2024-11-15 |
| Actual end date | 2024-11-11 |
| Shortage status | Resolved |
| Updated date | 2024-11-12 |
| Company comments | This is the only Ready to Use Insulin in the market. Many hospitals have converted to this format for safety. We will be stocking out many hospitals and are dependent on this release from Health Canada. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2024-11-12 | English | Compare |
| v12 | 2024-11-11 | French | Compare |
| v11 | 2024-11-11 | English | Compare |
| v10 | 2024-11-08 | French | Compare |
| v9 | 2024-11-08 | English | Compare |
| v8 | 2024-11-04 | French | Compare |
| v7 | 2024-11-04 | English | Compare |
| v6 | 2024-11-01 | French | Compare |
| v5 | 2024-11-01 | English | Compare |
| v4 | 2024-10-29 | English | Compare |
| v3 | 2024-10-24 | French | Compare |
| v2 | 2024-10-24 | English | Compare |
| v1 | 2024-10-24 | English | Compare |
Showing 1 to 13 of 13